title: A reduced intensity conditioning regimen of fludarabine, cyclophosphamide, antithymocyte globulin, plus 2 Gy TBI facilitates successful hematopoietic cell engraftment in an adult with dyskeratosis congenita.
authors.forename: M A
authors.initials: MA
authors.lastname: Kharfan-Dabaja
authors.forename: Z K
authors.initials: ZK
authors.lastname: Otrock
authors.forename: A
authors.initials: A
authors.lastname: Bacigalupo
authors.forename: R A
authors.initials: RA
authors.lastname: Mahfouz
authors.forename: F
authors.initials: F
authors.lastname: Geara
authors.forename: A
authors.initials: A
authors.lastname: Bazarbachi
mesh_terms: D000328:Adult; D000961:Antilymphocyte Serum / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use*; D019871:Dyskeratosis Congenita / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D008297:Male; D019172:Transplantation Conditioning / Q000379:methods*; D014740:Vidarabine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014916:Whole-Body Irradiation / Q000379:methods*
chemical_list: D000961:Antilymphocyte Serum; D003520:Cyclophosphamide; D014740:Vidarabine; C024352:fludarabine